Maurie Balch

Maurie was a postdoc in the lab from 2018-2020.  She is originally from Lavaca, Arkansas.  She graduated in 2011 with a B.S. in Chemistry from the University of Arkansas, Fort Smith.  In 2012, she joined the laboratory of Dr. Robert Matts at Oklahoma State University, and studied the heat shock protein Hsp90 and its role in cancer.  She graduated with her PhD in Biochemistry and Molecular Biology from OSU in July of 2018.  Maurie went on to work as a scientist at the FDA.

Chen S, Puri A, Bell B, Fritsche J, Palacios HH, Balch M, Sprunger ML, Howard MK, Ryan JJ, Haines JN, Patti GJ, Davis AA, and Jackrel ME (2024). HTRA1 disaggregates α-synuclein amyloid fibrils and coverts them into non-toxic and seeding incompetent species. Nat. Commun. 15: 2436. link

2. Khandelwal A., Kent C.N., Balch M., Peng S., Mishra S.J., Deng J., Day V.W., Liu W., Subramanian C., Cohen M., Holzbeierlein J.M., Matts R., and Blagg B.S.J. (2018) Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor. Nat. Commun. 9(1):425.
doi: 10.1038/s41467-017-02013-1.

3. Voruganti S., Kline J.T., Balch M.J., Rogers J., Matts R.L., and Hartson S.D. (2018).Proteomic Profiling of Hsp90 Inhibitors. Methods Mol Biol. 1709:139-162.
doi: 10.1007/978-1-4939-7477-1_11.

4. Davenport J., Balch M., Galam L., Girgis A., Hall J., Blagg B.S., and Matts R.L. (2014) High-throughput screen of natural product libraries for hsp90 inhibitors. Biology (Basel). 3(1):101-38.
doi: 10.3390/biology3010101.